BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12562253)

  • 21. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inherited forms of bladder cancer: a review of Lynch syndrome and other inherited conditions.
    Phelan A; Lopez-Beltran A; Montironi R; Zhang S; Raspollini MR; Cheng M; Kaimakliotis HZ; Koch MO; Cheng L
    Future Oncol; 2018 Feb; 14(3):277-290. PubMed ID: 29345160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.
    Leach FS; Hsieh JT; Molberg K; Saboorian MH; McConnell JD; Sagalowsky AI
    Cancer; 2000 May; 88(10):2333-41. PubMed ID: 10820356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is hereditary nonpolyposis colorectal cancer (HNPCC).
    Vasen HF
    Anticancer Res; 1994; 14(4B):1613-5. PubMed ID: 7979195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical implications of molecular diagnosis in hereditary nonpolyposis colorectal cancer.
    Möslein G
    Recent Results Cancer Res; 2003; 162():73-8. PubMed ID: 12790322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors.
    Lonati C; Necchi A; Gómez Rivas J; Afferi L; Laukhtina E; Martini A; Ventimiglia E; Colombo R; Gandaglia G; Salonia A; Briganti A; Montorsi F; Mattei A; Simeone C; Carlo MI; Shariat SF; Spiess PE; Moschini M;
    Eur Urol Oncol; 2022 Feb; 5(1):30-41. PubMed ID: 34896051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas].
    Olschwang S; Bonaïti C; Feingold J; Frébourg T; Grandjouan S; Lasset C; Laurent-Puig P; Lecuru F; Millat B; Sobol H; Thomas G; Eisinger F
    Bull Cancer; 2004 Apr; 91(4):303-15. PubMed ID: 15242312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HNPCC (hereditary non-polyposis colorectal cancer) or Lynch syndrome: a syndrome related to a failure of DNA repair system].
    Manceau G; Karoui M; Charachon A; Delchier JC; Sobhani I
    Bull Cancer; 2011 Mar; 98(3):323-36. PubMed ID: 21459714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC).
    Hegde MR; Roa BB
    Curr Protoc Hum Genet; 2009 Apr; Chapter 10():Unit 10.12. PubMed ID: 19360696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular cancer disposition diagnosis exemplified by colorectal carcinoma. What is the contribution of pathology?].
    Rüschoff J; Dietmaier W; Bocker T; Wallinger S; Kullmann F; Beham A; Hofstädter F
    Pathologe; 1998 Jul; 19(4):269-78. PubMed ID: 9746911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Should we systematically screen for Lynch syndrome in patients with upper urinary tract carcinoma?].
    Olagui GS; Pignot G; Rouquette A; Vieillefond A; Amsellem-Ouazana D; de Longchamps NB; Radenen B; Zerbib M; Terris B
    Bull Cancer; 2014 Feb; 101(2):144-50. PubMed ID: 24556207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A Case of Diagnosed Lynch Syndrome in a Patient with Ureteral Cancer].
    Kobayashi G; Takayanagi A; Shindo T; Hashimoto K; Kobayashi K; Fukuta F; Tanaka T; Masumori N
    Hinyokika Kiyo; 2021 Jun; 67(6):229-232. PubMed ID: 34265897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing.
    Christensen M; Katballe N; Wikman F; Primdahl H; Sørensen FB; Laurberg S; Ørntoft TF
    Cancer; 2002 Dec; 95(11):2422-30. PubMed ID: 12436451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined molecular and clinical approach for decision making for surgery in HNPCC patients: a report on three cases in two families.
    Pistorius SR; Nagel M; Kruger S; Plaschke J; Kruppa C; Wehrmann U; Schackert HK; Saeger HD
    Int J Colorectal Dis; 2001 Nov; 16(6):402-7. PubMed ID: 11760904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations.
    Syngal S; Weeks JC; Schrag D; Garber JE; Kuntz KM
    Ann Intern Med; 1998 Nov; 129(10):787-96. PubMed ID: 9841584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in hereditary nonpolyposis colorectal cancer.
    Craanen ME; Blok P; Offerhaus GJ; Tytgat GN
    Scand J Gastroenterol Suppl; 1996; 218():92-7. PubMed ID: 8865457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)].
    Vasen HF
    Fam Cancer; 2005; 4(3):219-25. PubMed ID: 16136381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary colorectal cancer syndromes.
    Strate LL; Syngal S
    Cancer Causes Control; 2005 Apr; 16(3):201-13. PubMed ID: 15947872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.